Curious about stem cells? Vail Symposium discusses the future of regenerative medicine

Stem cells are a hot topic in the medical world. As stem cells have transitioned from an area of medical research to clinical therapy with multiple applications, questions have arisen such as “where have they been most successful,” “what are the limitations,” “what are the implications for longevity,” and “where does the science go from here?”  

On Tuesday, June 25, at Eagle River Presbyterian Church in Avon, Vail Symposium brings together two leading stem cell experts to delve into this fascinating area of medical opportunity. Dr. Johnny Huard, chief scientific officer and director at the Linda & Mitch Hart Center for Regenerative and Personalized Medicine at the Steadman Philippon Research Institute, and Dr. George Muschler, professor of Orthopedic Surgery and Biomedical Engineering at the Cleveland Clinic, explore the current state of stem cell research and integration into our medical future.

“This has been one of our most requested topics in recent years,” said Vail Symposium Executive Director James Kenly. “We are fortunate to present these two world-class resources and we look forward to insightful questions from our community as well.”

Since the Vail Symposium last explored stem cells in 2019, the research and application of stem cells and derivative therapies have greatly advanced. Using accessible analogies to make this complicated research accessible to everyone, Huard and Muschler will answer questions about advances in therapies in regenerative medicine, osteoarthritis, autoimmune diseases, cancer, neurodegenerative diseases such as Alzheimer’s and Parkinson’s Diseases, and more.